Chronic myeloid leukemia (CML) is a hematological cancer that is predominantly caused by BCR-ABL translocations and for which targeted therapies have revolutionized cancer treatment18. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.